PREVENTING CERVICAL    CANCER ACROSS THE GLOBE

69CC11FD-2E49-4464-B2DB-4D80E2371933_1_105_c.jpeg
ananyaHealthLogo-square.png
 
1F87B45C-4C2F-40B1-AE1B-5EC82D83616B_1_105_c.jpeg

Although cervical cancer is virtually 100% preventable, more than 40 million women
each year lack access to early prevention technologies due to infrastructure constraints.


Ananya Health is building a portable medical device to treat cervical pre-cancer in the highest-burden regions of the world.

OF GLOBAL HEALTH RESEARCH AND INNOVATION GOES TO SUPPORT ONLY

OF THE WORLD'S DISEASE BURDEN.

90%

10%

people on own.png
updated pie chart.png

We're changing that.

Patients and doctors in the hardest-to-reach areas of the world cannot be served with the same designs as highly resourced medtech markets. They deserve products that are thoughtfully composed for their unique considerations and needs.

Ananya Health makes affordable, appropriate technologies that address the biggest issues in global health.

Why cervical cancer?

Cervical cancer is virtually entirely preventable, yet each year, 550,000 women contract the disease and 310,000 of them will die [WHO].


Pap smears and early treatment have drastically reduced incidence rates of cervical cancer in the US and Europe - so much that 90% of diagnoses occur in countries with limited access to these resources.

 

We have the tools to screen women for cancer early, but we don't have the tools to treat women where power is spotty and infrastructure is lacking. 

That’s where Ananya Health comes in.

99.7%

310,000

OF CERVICAL CANCER IS PREVENTABLE

WOMEN DIE FROM CERVICAL CANCER EACH YEAR

90%

OF DIAGNOSES OCCUR IN LOW AND MIDDLE INCOME COUNTRIES

Our challenge is to ensure that...every woman over 30 is screened and treated for pre-cancerous lesions.  To achieve that, we need innovative technologies and strategies.

Dr. Tedros Ghebreyesus

Director-General, WHO

May 2018

Meet Ala

ANANYA HEALTH'S PORTABLE,

SELF-CONTAINED CRYOTHERAPY

PLATFORM

What We're Building

Cryotherapy is a method of freezing tissue so that the body can replace it with healthy cells. In the cervix, precancerous lesions are identified through visual inspection and frozen off. Unfortunately, these procedures are traditionally difficult to access because of supply chain and power issues.​

Our battery-powered platform, Ala, achieves ablative temperatures while being compact and dependable, making it ideal for clinics in India, Africa, and emerging markets where cervical cancer is most prevalent.

 

We enable screening & treatment in a single visit, at any clinic in the world.

 

Ala

Standard Cryoablation 

VS

Traditional systems need to be plugged in, relying on a stable power grid 

Portable, battery-powered system can be used by trained health workers in any setting — from mobile clinic to hospital

Requires bulky canisters of compressed gas that need to be refilled

Reliance on expensive infrastructure raises cost per procedure

money stacks translucent.png
gas canisters translucent_.png

Closed-system ablation removes reliance

on heavy, hard-to-find compressed gas

Enables treatment at $1-$2

per procedure — 1/10 the

cost of other gas-based cryoablation systems

money stacks small.png

THE TEAM

Anu Headshot.png
ANU PARVATIYAR

Co-Founder & CEO

Anu is responsible for Ananya Health’s vision, fundraising, partnerships, and product pipeline. She has a decade of experience in medical devices and public health. Anu has launched Class II devices in the cardiac, vascular, and urology spaces, and she led a Global Programs team at eHealth Africa, where her team of 300 staff helped eradicate polio in Nigeria. She holds a B.S. in Biomedical Engineering from Georgia Tech.

IMG_7522_edited.jpg
CHRIS SKIELLER

Principal Engineer

Julie headshot.png
JULIE YIP

Co-Founder & Engineer

Julie develops cryo technology at Ananya Health, approaching every challenge with a user-focused mindset. She has worked on multiple medical devices and research initiatives in femtech and global health. She holds a B.S. in Bioengineering from UC San Diego.  

dan headshot brighter.png
DANIEL BURNETT

Co-Founder & Medical Advisor

IMG_7581.JPG
ALLEN CHANG

CTO

Allen leads product development and quality. He co-founded Vertera Spine, which was acquired by NuVasive, and has launched several novel implants that improve patient outcomes. He was selected in Forbes 30 Under 30 and holds a B.S. from Georgia Tech and M.Eng. from Boston University, both in Biomedical Engineering.

PXL_20221020_203707104_edited.jpg
JON SILBERSTEIN

Consulting Engineer

Chris supports Ananya Health's engineering efforts. She brings a decade of experience in medical device startups and a passion for women's health and sustainability. She has had two exits, including the ovarian cancer diagnostics company nVision Medical, which was acquired by Boston Scientific. She holds a B.S. in Mechanical Engineering from Stanford University. 

Dan supports Ananya Health's product and clinical strategy. He is also the CEO and Founder of Theranova, a medical device incubator.  Dan holds a B.S. in Bioengineering from UPenn and an M.D./MBA from Duke University.

Jon designs and programs electronics and firmware. He  has seven years of experience in medical devices and clinical trials. He was the first employee at Piccolo Medical with the FDA cleared smartPICC device, and he holds a B.S. in Bioengineering from the University of California, Berkeley.

IMG_7590_edited.jpg
0_edited_edited.jpg
ANANYA MADHAV

Graduate Intern

SOPHIA BURNETT

Intern

Contact Us

101 Mississippi Street, San Francisco, CA 94107

 hi@ananya.health

  • Twitter
  • Instagram

Thanks for reaching out!